Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study.

Matthias Loehr,Maximilian Kordes,Linnéa Malgerud,Sajo Kaduthanam,Jan Erik Frödin,Masoud Karimi,Jeffrey Yachnin,Carlos Fernández Moro,Sam Ghazi,Rainer Heuchel,Valtteri Wirta,Carolin Hülsewig,Katrin Stecker,Marco Del Chiaro,Arne Östman,Engstrand Lars,Stephan Brock,Maria Gustavsson-Liljefors

Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study.

2018

Matthias Loehr
Maximilian Kordes
Linnéa Malgerud
Sajo Kaduthanam
Jan Erik Frödin
Masoud Karimi
Jeffrey Yachnin
Carlos Fernández Moro
Sam Ghazi
Rainer Heuchel
Valtteri Wirta
Carolin Hülsewig
Katrin Stecker
Marco Del Chiaro
Arne Östman
Engstrand Lars
Stephan Brock
Maria Gustavsson-Liljefors

e16214Background: Pancreatic cancer (PDAC) is almost resistant to therapy, yet some patients profit from targeted therapy. We performed NGS on PDAC tissue and evidence-based, AI-supported evaluatio...

Keywords:

Software
Evidence-based practice
Pancreatic cancer
Pathology
Medicine
Oncology
Targeted therapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations